Japan
· Delayed Price · Currency is JPY Hisamitsu Pharmaceutical Co. Statistics
Total Valuation
Hisamitsu Pharmaceutical Co. has a market cap or net worth of JPY 331.34 billion. The enterprise value is 220.03 billion.
| Market Cap | 331.34B |
| Enterprise Value | 220.03B |
Important Dates
The last earnings date was Thursday, January 9, 2025.
| Earnings Date | Jan 9, 2025 |
| Ex-Dividend Date | Feb 27, 2025 |
Share Statistics
Hisamitsu Pharmaceutical Co. has 72.93 million shares outstanding. The number of shares has decreased by -6.03% in one year.
| Current Share Class | n/a |
| Shares Outstanding | 72.93M |
| Shares Change (YoY) | -6.03% |
| Shares Change (QoQ) | -0.17% |
| Owned by Insiders (%) | 0.73% |
| Owned by Institutions (%) | 44.67% |
| Float | 67.85M |
Valuation Ratios
The trailing PE ratio is 21.76 and the forward PE ratio is 20.42.
| PE Ratio | 21.76 |
| Forward PE | 20.42 |
| PS Ratio | 2.25 |
| PB Ratio | 1.27 |
| P/TBV Ratio | 1.31 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | 14.16 |
| EV / Sales | 1.47 |
| EV / EBITDA | 11.07 |
| EV / EBIT | 15.13 |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 3.54, with a Debt / Equity ratio of 0.01.
| Current Ratio | 3.54 |
| Quick Ratio | 2.90 |
| Debt / Equity | 0.01 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | 673.43 |
Financial Efficiency
| Return on Equity (ROE) | n/a |
| Return on Assets (ROA) | n/a |
| Return on Capital (ROIC) | n/a |
| Revenue Per Employee | 54.42M |
| Profits Per Employee | 5.63M |
| Employee Count | 2,759 |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +8.81% in the last 52 weeks. The beta is 0.34, so Hisamitsu Pharmaceutical Co.'s price volatility has been lower than the market average.
| Beta (5Y) | 0.34 |
| 52-Week Price Change | +8.81% |
| 50-Day Moving Average | 4,267.02 |
| 200-Day Moving Average | 4,011.76 |
| Relative Strength Index (RSI) | 65.46 |
| Average Volume (20 Days) | 238,910 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, Hisamitsu Pharmaceutical Co. had revenue of JPY 150.13 billion and earned 15.54 billion in profits. Earnings per share was 208.81.
| Revenue | 150.13B |
| Gross Profit | 86.76B |
| Operating Income | 14.14B |
| Pretax Income | 21.96B |
| Net Income | 15.54B |
| EBITDA | 19.48B |
| EBIT | 14.14B |
| Earnings Per Share (EPS) | 208.81 |
Balance Sheet
The company has 116.64 billion in cash and 2.93 billion in debt, giving a net cash position of 113.71 billion or 1,559.10 per share.
| Cash & Cash Equivalents | 116.64B |
| Total Debt | 2.93B |
| Net Cash | 113.71B |
| Net Cash Per Share | 1,559.10 |
| Equity (Book Value) | 262.29B |
| Book Value Per Share | 3,563.29 |
| Working Capital | 140.92B |
Cash Flow
| Operating Cash Flow | n/a |
| Capital Expenditures | n/a |
| Free Cash Flow | n/a |
| FCF Per Share | n/a |
Margins
| Gross Margin | n/a |
| Operating Margin | 9.42% |
| Pretax Margin | 14.63% |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
This stock pays an annual dividend of 86.00, which amounts to a dividend yield of 1.87%.
| Dividend Per Share | 86.00 |
| Dividend Yield | 1.87% |
| Dividend Growth (YoY) | 3.24% |
| Years of Dividend Growth | 8 |
| Payout Ratio | n/a |
| Buyback Yield | 6.03% |
| Shareholder Yield | 7.90% |
| Earnings Yield | 4.60% |
| FCF Yield | n/a |
Stock Splits
The last stock split was on June 27, 2000. It was a forward split with a ratio of 2.
| Last Split Date | Jun 27, 2000 |
| Split Type | Forward |
| Split Ratio | 2 |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | n/a |